Sign in
Taking people in United StatesNo phase

Mapping heart electrical pathways in repaired tetralogy of Fallot before a pulmonary valve replacement

Maps electrical signals in the right ventricle of people with repaired tetralogy of Fallot.

Key facts

Who runs it
Boston Children's Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot
Status
Recruiting
People taking part
60 people, planned
Started
4 Nov 2022
Planned end
1 Jan 2024
Type of study
Interventional
Treatments tested
  • Electroanatomic substrate mapping
Record updated
8 February 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with repaired tetralogy of Fallot or double outlet right ventricle who are referred for a pulmonary valve replacement done through a catheter (TPVR). Their heart's electrical activity will be mapped before the procedure.

Sex
All sexes can join.
Disease stage
Tetralogy of Fallot (TOF) or double outlet right ventricle (DORV), heart defects present from birth.
Earlier treatment
People must be referred for transcatheter pulmonary valve replacement (TPVR) for usual clinical reasons.

Main reasons for not taking part

  • Weight under 25 kg (55 lb).

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Diagnosis of tetralogy of Fallot (TOF) or double outlet right ventricle (DORV)
  • Referred for transcatheter pulmonary valve replacement (TPVR) per routine clinical indications
  • Weight >=25 kg

Where in United States

  • Boston Children's HospitalBoston, United StatesContact: Edward T O'Leary, MDTaking people

About the trial

What the trial wants to find out

Individuals with repaired Tetralogy of Fallot (rTOF) remain at risk for sudden cardiac death from ventricular tachycardia (VT). Transcatheter pulmonary valve replacement (TPVR) indications continue to broaden, yet its capability to reduce the risk of VT and sudden cardiac death remains unknown. Thus, in a cohort of participants with rTOF who are presenting for TPVR the investigators intend to: (1) quantify and localize right ventricular (RV) isthmuses with abnormal voltage and/or conduction velocity; (2) identify which RV isthmuses are at risk of being "jailed" by TPV prostheses; and (3) explore the feasibility of omnipolar technology to characterize wavefront directionality and differentiate slow conduction from conduction block.

The group in the trial

  • RV mappingOther group

    Participants will undergo a sinus rhythm electroanatomic RV substrate map prior to TPVR.

    Treatment: Electroanatomic substrate mapping

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses and Anatomic Isthmuses in Repaired Tetralogy of Fallot
Plain-language title
Mapping heart electrical pathways in repaired tetralogy of Fallot before a pulmonary valve replacementGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
8 February 2023